Compare YALA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YALA | ABCL |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United Arab Emirates | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 2020 |
| Metric | YALA | ABCL |
|---|---|---|
| Price | $6.56 | $3.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 323.6K | ★ 2.4M |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,128,000.00 |
| Revenue This Year | $16.40 | N/A |
| Revenue Next Year | $7.13 | $25.44 |
| P/E Ratio | $8.76 | ★ N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $5.13 | $1.94 |
| 52 Week High | $9.29 | $6.52 |
| Indicator | YALA | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 49.10 |
| Support Level | $6.04 | $3.37 |
| Resistance Level | $7.32 | $3.84 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 77.56 | 43.33 |
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.